Atrial fibrillation (AFib) is one of the most common heart-rhythm problems and one of the most treatable causes of ischemic stroke. Not every person with AFib has the same stroke risk: a young patient with no other risk factors sits in a different place on the risk curve from an older patient with prior stroke, heart failure, and diabetes. The CHA2DS2-VASc score was built to put that risk into a simple bedside number so decisions about blood thinners rest on evidence rather than habit.1

Interactive tool

CHA2DS2-VASc Calculator

For nonvalvular atrial fibrillation. Select each factor; the score and approximate untreated annual stroke risk update instantly.

Congestive heart failure C
Hypertension H
Age A2 / A
Diabetes mellitus D
Prior stroke, TIA, or thromboembolism S2
Vascular disease V — prior MI, PAD, or aortic plaque
Sex category Sc
0 / 9
Lower risk

Educational tool only. Approximate untreated annual stroke rates are population estimates and vary by study; they do not predict any individual outcome. Anticoagulation decisions weigh stroke risk, bleeding risk, and patient preference and must be made with a clinician. If you may be having stroke symptoms now, call emergency services.

What each letter scores

The acronym is a memory aid for eight factors. Age is scored in one band only (0, 1, or 2 points), never stacked.1

  • C — Congestive heart failure (or moderate–severe LV dysfunction): 1 point.
  • H — Hypertension (history of high blood pressure): 1 point.
  • A2 — Age ≥ 75 years: 2 points.
  • D — Diabetes mellitus: 1 point.
  • S2 — Prior stroke, TIA, or systemic thromboembolism: 2 points.
  • V — Vascular disease (prior MI, peripheral artery disease, or aortic plaque): 1 point.
  • A — Age 65–74 years: 1 point.
  • Sc — Sex category female: 1 point.

Maximum total is 9. Female sex alone does not usually push someone into an anticoagulation band; most guidelines treat sex as a modifier that matters more once other risk factors are present.

How the score is used clinically

In broad strokes, current practice for nonvalvular AFib is: low scores may not need anticoagulation for stroke prevention alone; intermediate scores call for a careful discussion; higher scores usually favor oral anticoagulation unless bleeding risk is prohibitive. Direct oral anticoagulants (DOACs) are preferred over warfarin for most eligible patients. Aspirin alone is not an adequate substitute for anticoagulation when stroke risk from AFib is high.2

The score is only half the conversation. Bleeding risk (HAS-BLED calculator helps frame that side), fall risk, renal function, cost, and patient preference all matter. The calculator is a starting point for a shared decision, not a prescription.

Key point

A high CHA2DS2-VASc score means the stroke risk of untreated AFib is high enough that anticoagulation usually wins the risk–benefit math — not that the patient is destined for a stroke tomorrow, and not that every low score is “safe forever.” Risk is reassessed as people age and diagnoses accumulate.

What the score does not cover

It does not apply the same way to every form of atrial disease (for example, moderate-to-severe mitral stenosis and mechanical valves follow different rules). It does not estimate bleeding risk, decide which DOAC to pick, or replace imaging and workup after a stroke. And absolute annual percentages differ slightly across published tables — use them as order-of-magnitude guidance, not destiny.